236 related articles for article (PubMed ID: 34897033)
1. A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients.
Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
Aging (Albany NY); 2021 Dec; 13(23):25453-25465. PubMed ID: 34897033
[TBL] [Abstract][Full Text] [Related]
2. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
3. Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer.
Jiang Q; Chen H; Tang Z; Sun J; Ruan Y; Liu F; Sun Y
BMC Cancer; 2021 Sep; 21(1):1067. PubMed ID: 34587919
[TBL] [Abstract][Full Text] [Related]
4. Construction of an autophagy-related eleven long noncoding RNA signature to predict the outcomes, immune cell infiltration, and immunotherapy response in patients with gastric cancer.
Mu GC; Luo YJ; Chen JQ
J Physiol Pharmacol; 2023 Jun; 74(3):. PubMed ID: 37661182
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
6. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
8. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer.
Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C
Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744
[No Abstract] [Full Text] [Related]
9. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
10. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
11. A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.
Chen D; Wang M; Xu Y; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Int J Gen Med; 2021; 14():6935-6950. PubMed ID: 34703297
[TBL] [Abstract][Full Text] [Related]
12. Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer.
Bao T; Wang Z; Xu J
Front Surg; 2022; 9():807778. PubMed ID: 35402492
[TBL] [Abstract][Full Text] [Related]
13. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
14. A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC.
Fan X; Huang Y; Zhong Y; Yan Y; Li J; Fan Y; Xie F; Luo Q; Zhang Z
World J Surg Oncol; 2023 Aug; 21(1):250. PubMed ID: 37592311
[TBL] [Abstract][Full Text] [Related]
15. A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer.
Feng J; Tang X; Song L; Zhou Z; Jiang Y; Huang Y
J Cancer Res Clin Oncol; 2023 Jan; 149(1):135-146. PubMed ID: 36333566
[TBL] [Abstract][Full Text] [Related]
16. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer.
Yang Y; Zhou L; Gou X; Wu G; Zheng Y; Liu M; Chen Z; Wang Y; Ji R; Guo Q; Zhou Y
Math Biosci Eng; 2022 Jan; 19(1):595-611. PubMed ID: 34903003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
[TBL] [Abstract][Full Text] [Related]
19. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
[TBL] [Abstract][Full Text] [Related]
20. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
